Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
Diabetes, Obesity and Metabolism · 2024-06 · 26 (6) · 2082-2091
DOI: 10.1111/dom.15512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 26.02.2024. Verfasst von Xiaopeng Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Information Science and Engineering, Northeastern University, Shenyang, China. Hauptthemen laut MEDLINE: Albuminuria, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Program of Shanghai Academic Research Leader, National Natural Science Foundation of China, Shanghai Oriental Talent Program (Youth Project).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
The wealth of data generated by continuous glucose monitoring (CGM) provides new opportunities for revealing heterogeneities in patients with type 2 diabetes mellitus (T2DM). We aimed to develop a method using CGM data to discover T2DM subtypes and investigate their relationship with clinical phenotypes and microvascular complications.
Methods
The data from 3119 patients with T2DM who wore blinded CGM at an academic medical centre was collected, and a glucose symbolic pattern (GSP) metric was created that combined knowledge‐based temporal abstraction with numerical vectorization. The k‐means clustering was applied to GSP to obtain subgroups of patients with T2DM. Clinical characteristics and the presence of diabetic retinopathy and albuminuria were compared among the subgroups. The findings were validated in an independent population comprising 773 patients with T2DM.
Results
By using GSP, four subgroups were identified with distinct features in CGM profiles and parameters. Moreover, the clustered subgroups differed significantly in clinical phenotypes, including indices of pancreatic β‐cell function and insulin resistance (all p < .001). After adjusting for confounders, group C (the most insulin resistant) had a significantly higher risk of albuminuria (odds ratio = 1.24, 95% confidence interval: 1.03‐1.39) relative to group D, which had the best glucose control. These findings were confirmed in the validation set.
Conclusion
Subtyping patients with T2DM using CGM data may help identify high‐risk patients for microvascular complications and provide insights into the underlying pathophysiology. This method may help refine clinically meaningful stratification of patients with T2DM and inform personalized diabetes care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Information Science and Engineering, Northeastern University, Shenyang, China.
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai K…
Förderung
- Program of Shanghai Academic Research Leader
- National Natural Science Foundation of China
- Shanghai Oriental Talent Program (Youth Project)
- National Natural Science Foundation of China Youth Fund Project
Zitieren
APA
Shao, X., Lu, J., Tao, R., Wu, L., Wang, Y., Lu, W., Li, H., Zhou, J., & Yu, X. (2024). Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data. Diabetes, Obesity and Metabolism, 26(6), 2082-2091. https://doi.org/10.1111/dom.15512
Vancouver
Shao X, Lu J, Tao R, Wu L, Wang Y, Lu W, et al. Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data. Diabetes, Obesity and Metabolism. 2024;26(6):2082-2091. doi:10.1111/dom.15512
BibTeX
@article{Shao2024,
author = {Shao, Xiaopeng and Lu, Jingyi and Tao, Rui and Wu, Liang and Wang, Yaxin and Lu, Wei and Li, Hongru and Zhou, Jian and Yu, Xia},
title = {Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {6},
pages = {2082--2091},
doi = {10.1111/dom.15512}
}
EUVIMED